UBS Lux Equity Fund Biotech USD vs Nordnet Indexfond Global

UBS Lux Equity Fund Biotech USD vs Nordnet Indexfond Global

1. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

2. Nordnet Indexfond Global

  • Security

    Nordnet Indexfond Global ESG

  • Fee

    0.20%

  • ISIN

    IE00BMTD2G30

  • Holdings

    10

  • Number of owning funds

    2

Fund Holdings

We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.9) and Moderna (9.21). In comparison with Nordnet Indexfond Global, we have 22 holdings where Salesforce.com is the largest holding (0.78), followed by AstraZeneca (0.64) and Merck & Co (0.64).

All Holdings

Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Nordnet Indexfond Global.

UBS Lux Equity Fund Biotech USD Nordnet Indexfond Global
1. Regeneron Pharmaceuticals Inc
10.04 %
1. Salesforce.com Inc
USA
0.78 %
2. Vertex Pharmaceuticals Inc
9.9 %
2. AstraZeneca
Sweden UK
0.64 %
3. Moderna Inc
9.21 %
3. Merck & Co Inc
Germany
0.64 %
4. Alnylam Pharmaceuticals Inc
6.54 %
4. IBM Corp
USA
0.64 %
5. AbbVie Inc
USA
5.52 %
5. GE Aerospace
USA
0.62 %
6. Gilead Sciences Inc
USA
4.66 %
6. McDonald's Corp
USA
0.61 %
7. Amgen Inc
4.32 %
7. Linde Plc
Ireland
0.61 %
8. BioNTech SE
4.13 %
8. Accenture Plc
Ireland
0.6 %
9. Karuna Therapeutics Inc
3.75 %
9. HSBC Holdings PLC
UK
0.59 %
10. Royalty Pharma Plc
3.28 %
10. PepsiCo Inc
USA
0.58 %

The list of fund holdings was last updated on April 17, 2025.